144 related articles for article (PubMed ID: 9880529)
1. Induction of high mobility group-I(Y) protein by endotoxin and interleukin-1beta in vascular smooth muscle cells. Role in activation of inducible nitric oxide synthase.
Pellacani A; Chin MT; Wiesel P; Ibanez M; Patel A; Yet SF; Hsieh CM; Paulauskis JD; Reeves R; Lee ME; Perrella MA
J Biol Chem; 1999 Jan; 274(3):1525-32. PubMed ID: 9880529
[TBL] [Abstract][Full Text] [Related]
2. High mobility group-I(Y) protein facilitates nuclear factor-kappaB binding and transactivation of the inducible nitric-oxide synthase promoter/enhancer.
Perrella MA; Pellacani A; Wiesel P; Chin MT; Foster LC; Ibanez M; Hsieh CM; Reeves R; Yet SF; Lee ME
J Biol Chem; 1999 Mar; 274(13):9045-52. PubMed ID: 10085153
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of high mobility group-I(Y) protein contributes to the inhibition of nitric-oxide synthase 2 by transforming growth factor-beta1.
Pellacani A; Wiesel P; Razavi S; Vasilj V; Feinberg MW; Chin MT; Reeves R; Perrella MA
J Biol Chem; 2001 Jan; 276(2):1653-9. PubMed ID: 11056164
[TBL] [Abstract][Full Text] [Related]
4. Role of nuclear factor-kappaB activation in cytokine- and sphingomyelinase-stimulated inducible nitric oxide synthase gene expression in vascular smooth muscle cells.
Katsuyama K; Shichiri M; Marumo F; Hirata Y
Endocrinology; 1998 Nov; 139(11):4506-12. PubMed ID: 9794459
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia induces high-mobility-group protein I(Y) and transcription of the cyclooxygenase-2 gene in human vascular endothelium.
Ji YS; Xu Q; Schmedtje JF
Circ Res; 1998 Aug; 83(3):295-304. PubMed ID: 9710122
[TBL] [Abstract][Full Text] [Related]
6. Amlodipine increases nitric oxide synthesis in cytokine-stimulated cultured vascualar smooth muscle cells.
Ikeda U; Shimpo M; Ohki R; Takahashi M; Yamamoto K; Ikeda M; Minota S; Shimada K
J Hypertens; 2000 Nov; 18(11):1597-604. PubMed ID: 11081772
[TBL] [Abstract][Full Text] [Related]
7. An anti-ulcer drug, geranylgeranylacetone, suppresses inducible nitric oxide synthase in cultured vascular smooth muscle cells.
Yamamoto K; Sarukawa M; Ito T; Aoki H; Ichida M; Shimada K
J Hypertens; 2005 Oct; 23(10):1847-53. PubMed ID: 16148608
[TBL] [Abstract][Full Text] [Related]
8. Role of activating protein-1 and high mobility group-I(Y) protein in the induction of CD44 gene expression by interleukin-1beta in vascular smooth muscle cells.
Foster LC; Wiesel P; Huggins GS; Pañares R; Chin MT; Pellacani A; Perrella MA
FASEB J; 2000 Feb; 14(2):368-78. PubMed ID: 10657993
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide differentially regulates induction of type II nitric oxide synthase in rat vascular smooth muscle cells versus macrophages.
Zhang H; Snead C; Catravas JD
Arterioscler Thromb Vasc Biol; 2001 Apr; 21(4):529-35. PubMed ID: 11304468
[TBL] [Abstract][Full Text] [Related]
10. The role of Rho-associated kinase in differential regulation by statins of interleukin-1beta- and lipopolysaccharide-mediated nuclear factor kappaB activation and inducible nitric-oxide synthase gene expression in vascular smooth muscle cells.
Wei CY; Huang KC; Chou YH; Hsieh PF; Lin KH; Lin WW
Mol Pharmacol; 2006 Mar; 69(3):960-7. PubMed ID: 16317111
[TBL] [Abstract][Full Text] [Related]
11. An octamer motif is required for activation of the inducible nitric oxide synthase promoter in pancreatic beta-cells.
Darville MI; Terryn S; Eizirik DL
Endocrinology; 2004 Mar; 145(3):1130-6. PubMed ID: 14630716
[TBL] [Abstract][Full Text] [Related]
12. Vicinal dithiol-binding agent, phenylarsine oxide, inhibits inducible nitric-oxide synthase gene expression at a step of nuclear factor-kappaB DNA binding in hepatocytes.
Oda M; Sakitani K; Kaibori M; Inoue T; Kamiyama Y; Okumura T
J Biol Chem; 2000 Feb; 275(6):4369-73. PubMed ID: 10660607
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of nitric oxide accumulation by cyclooxygenase-2 induction and thromboxane A2 production in interleukin-1beta-stimulated rat aortic smooth muscle cells.
Shiokoshi T; Ohsaki Y; Kawabe J; Fujino T; Kikuchi K
J Hypertens; 2002 Mar; 20(3):455-61. PubMed ID: 11875313
[TBL] [Abstract][Full Text] [Related]
14. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors upregulate inducible NO synthase expression and activity in vascular smooth muscle cells.
Kolyada AY; Fedtsov A; Madias NE
Hypertension; 2001 Nov; 38(5):1024-9. PubMed ID: 11711492
[TBL] [Abstract][Full Text] [Related]
15. Statin enhances cytokine-mediated induction of nitric oxide synthesis in vascular smooth muscle cells.
Hattori Y; Nakanishi N; Kasai K
Cardiovasc Res; 2002 Jun; 54(3):649-58. PubMed ID: 12031711
[TBL] [Abstract][Full Text] [Related]
16. Induction by staurosporine of nitric oxide synthase expression in vascular smooth muscle cells: role of NF-kappa B, CREB and C/EBP beta.
Hecker M; Preiss C; Schini-Kerth VB
Br J Pharmacol; 1997 Mar; 120(6):1067-74. PubMed ID: 9134219
[TBL] [Abstract][Full Text] [Related]
17. Homocysteine-induced nitric oxide production in vascular smooth-muscle cells by NF-kappa B-dependent transcriptional activation of Nos2.
Welch GN; Upchurch GR; Farivar RS; Pigazzi A; Vu K; Brecher P; Keaney JF; Loscalzo J
Proc Assoc Am Physicians; 1998; 110(1):22-31. PubMed ID: 9460080
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms of inducible nitric oxide synthase gene expression by IL-1beta and cAMP in rat mesangial cells.
Eberhardt W; Plüss C; Hummel R; Pfeilschifter J
J Immunol; 1998 May; 160(10):4961-9. PubMed ID: 9590244
[TBL] [Abstract][Full Text] [Related]
19. Cycloprodigiosin up-regulates inducible nitric oxide synthase gene expression in hepatocytes stimulated by interleukin-1beta.
Teshima S; Nakanishi H; Kamata K; Kaibori M; Kwon AH; Kamiyama Y; Nishizawa M; Ito S; Okumura T
Nitric Oxide; 2004 Aug; 11(1):9-16. PubMed ID: 15350552
[TBL] [Abstract][Full Text] [Related]
20. HMG-CoA reductase inhibitor enhances inducible nitric oxide synthase expression in rat vascular smooth muscle cells; involvement of the Rho/Rho kinase pathway.
Yamamoto T; Takeda K; Harada S; Nakata T; Azuma A; Sasaki S; Nakagawa M
Atherosclerosis; 2003 Feb; 166(2):213-22. PubMed ID: 12535733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
